Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects

NCT03007810 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Hemay005
DRUG: Placebos

Sponsor

Tianjin Hemay Bio-Tech Co., Ltd